These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 954347)

  • 1. Absolute quinidine bioavailability.
    Ueda CT; Williamson BJ; Dzindzio BS
    Clin Pharmacol Ther; 1976 Sep; 20(3):260-5. PubMed ID: 954347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quinidine pharmacokinetics in man: choice of a disposition model and absolute bioavailability studies.
    Guentert TW; Holford NH; Coates PE; Upton RA; Riegelman S
    J Pharmacokinet Biopharm; 1979 Aug; 7(4):315-30. PubMed ID: 512840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioavailability of quinidine in congestive heart failure.
    Ueda CT; Dzindzio BS
    Br J Clin Pharmacol; 1981 Jun; 11(6):571-7. PubMed ID: 7272173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of quinidine and three of its metabolites in man.
    Rakhit A; Holford NH; Guentert TW; Maloney K; Riegelman S
    J Pharmacokinet Biopharm; 1984 Feb; 12(1):1-21. PubMed ID: 6747817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioavailability of a commercial sustained-release quinidine tablet compared to oral quinidine solution.
    Sawyer WT; Pulliam CC; Mattocks A; Foster J; Hadzija BW; Rosenthal HM
    Biopharm Drug Dispos; 1982; 3(4):301-10. PubMed ID: 7159686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetic studies of quinidine in patients with arrhythmias.
    Conrad KA; Molk BL; Chidsey CA
    Circulation; 1977 Jan; 55(1):1-7. PubMed ID: 830196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioavailability of 11 quinidine formulations adn pharmacokinetic variation in humans.
    McGilveray IJ; Midha KK; Rowe M; Beaudoin N; Charette C
    J Pharm Sci; 1981 May; 70(5):524-9. PubMed ID: 7241357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Absolute bioavailability of quinidine in two sustained release preparations.
    Amlie JP; Storstein L; Olsson B; Fremstad D; Jacobsen S
    Eur J Clin Pharmacol; 1979 Aug; 16(1):45-8. PubMed ID: 499299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disposition kinetics of two oral forms of quinidine.
    Mahon WA; Mayersohn M; Inaba T
    Clin Pharmacol Ther; 1976 May; 19(5 Pt 1):566-75. PubMed ID: 1277713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of quinidine plasma concentration curves following oral administration of some short- and long-acting formulations.
    Frigo GM; Perucca E; Teggia-Droghi M; Gatti G; Mussini A; Salerno J
    Br J Clin Pharmacol; 1977 Aug; 4(4):449-54. PubMed ID: 901736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of hydroxy-3(S)-dihydroquinidine in healthy volunteers after intravenous and oral administration.
    Jaillon P; Poirier JM; Lecocq B; Jarreau C; Pays M; Richard MO; Cheymol G
    Eur J Drug Metab Pharmacokinet; 1986; 11(3):233-8. PubMed ID: 3816879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of quinidine in humans after intravenous, intramuscular and oral administration.
    Greenblatt DJ; Pfeifer HJ; Ochs HR; Franke K; MacLaughlin DS; Smith TW; Koch-Weser J
    J Pharmacol Exp Ther; 1977 Aug; 202(2):365-78. PubMed ID: 577934
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmacokinetic analysis of intravenously and orally administered quinidine in cows.
    McGuirk SM; Muir WW; Sams RA
    Am J Vet Res; 1981 Sep; 42(9):1482-7. PubMed ID: 7325456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Absorption of quinidine from an enteric-coated preparation.
    Fremstad D; Nilsen OG; Amlie J; Storstein L; Olsson B; Jacobsen S
    Eur J Clin Pharmacol; 1979 Sep; 16(2):107-12. PubMed ID: 499306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic analysis of intravenously and orally administered quinidine in horses.
    McGuirk SM; Muir WW; Sams RA
    Am J Vet Res; 1981 Jun; 42(6):938-42. PubMed ID: 7283244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disposition kinetics of quinidine.
    Ueda CT; Hirschfeld DS; Scheinman MM; Rowland M; Williamson BJ; Dzindzio BS
    Clin Pharmacol Ther; 1976 Jan; 19(1):30-6. PubMed ID: 1245091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The bioavailability and kinetics of dihydroquinidine in patients with heart disease.
    Regazzi Bonora M; Salerno JA; Rondanelli R; Cristiani D; Chimienti M
    Int J Clin Pharmacol Ther Toxicol; 1982 May; 20(5):212-8. PubMed ID: 7095920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative bioavaiability of four commercial quinidine sulfate tablets.
    Strum JD; Colaizzi JL; Jaffe JM; Martineau PC; Poust RI
    J Pharm Sci; 1977 Apr; 66(4):539-42. PubMed ID: 576879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concentration-time effects of quinidine disposition kinetics in rhesus monkeys.
    Ueda CT; Ballard B; Rowland M
    J Pharmacol Exp Ther; 1977 Mar; 200(3):459-68. PubMed ID: 403278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The absolute bioavailability of caffeine in man.
    Blanchard J; Sawers SJ
    Eur J Clin Pharmacol; 1983; 24(1):93-8. PubMed ID: 6832208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.